Get the Stockscreener App
129.50
1.42%
1.81
Davita Inc stock is traded at $129.50, with a volume of 949.57K.
It is up +1.42% in the last 24 hours and down -9.94% over the past month.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
See More
Previous Close:
$127.69
Open:
$128.33
24h Volume:
949.57K
Relative Volume:
1.11
Market Cap:
$9.78B
Revenue:
$12.82B
Net Income/Loss:
$936.34M
P/E Ratio:
12.06
EPS:
10.74
Net Cash Flow:
$1.47B
1W Performance:
-6.48%
1M Performance:
-9.94%
6M Performance:
-25.39%
1Y Performance:
-6.75%
1-Day Range:
$127.32
$130.51
1-Week Range:
$126.07
$141.52
52-Week Range:
$126.07
$179.60
Davita Inc Stock (DVA) Company Profile
Name
Davita Inc
Sector
Industry
Phone
310-536-2668
Address
2000 16TH STREET, DENVER, CO
Compare DVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
129.50 | 9.14B | 12.82B | 936.34M | 1.47B | 10.74 |
|
HCA
Hca Healthcare Inc
|
381.61 | 85.68B | 72.70B | 5.97B | 7.29B | 23.79 |
|
THC
Tenet Healthcare Corp
|
165.58 | 14.07B | 20.52B | 1.46B | 1.41B | 15.12 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.07 | 13.80B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
EHC
Encompass Health Corp
|
117.58 | 11.75B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
172.30 | 10.53B | 16.08B | 1.20B | 1.06B | 17.82 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Aug-07-23 | Upgrade | UBS | Neutral → Buy |
| Nov-01-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-31-22 | Downgrade | UBS | Buy → Neutral |
| Aug-19-22 | Resumed | UBS | Buy |
| Jun-21-22 | Reiterated | BofA Securities | Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-12-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-26-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-05-21 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-24-20 | Upgrade | Goldman | Neutral → Buy |
| Nov-07-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-25-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-11-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-26-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-19 | Upgrade | UBS | Sell → Neutral |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Dec-14-18 | Initiated | Barclays | Overweight |
| Nov-28-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-16-18 | Initiated | UBS | Sell |
| Nov-08-18 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Sep-13-18 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-04-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Dec-12-17 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-11-17 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-17 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-08-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-09-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-26-17 | Downgrade | Jefferies | Buy → Hold |
| Dec-13-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Davita Inc Stock (DVA) Latest News
Can DaVita’s (DVA) Share Buybacks Offset Mixed Q2 Earnings Trends? - simplywall.st
DaVita Inc. (NYSE:DVA) Q2 2025 Earnings Call Transcript - MSN
Barclays Updates DaVita (DVA) with Lower Price Target to $160 | - GuruFocus
DaVita Shares Plunge 9% Amid 150% Volume Surge to $430M, Rank 264th in Market Activity - AInvest
DaVita 2025 Q2 Earnings Net Income Falls 8.2% Despite Revenue Growth - AInvest
DaVita Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DaVita Stock Down Despite Q2 Earnings Beat, Gross Margin Expands - The Globe and Mail
DaVita Inc. Stock Dives 8.5% on Declining Treatment Volumes and Forecast CutNews and Statistics - IndexBox
Why DaVita (DVA) Stock Is Nosediving - Yahoo Finance
Huge healthcare breach sees nearly a million patients hit following DaVita ransomware attackmake sure you're safe - TechRadar
Barclays Adjusts DaVita Price Target to $160 From $169 - MarketScreener
DaVita stock hits 52-week low at $131.09 amid market fluctuations - Investing.com Nigeria
Over 900K hit by DaVita ransomware hack - SC Media
DaVita 2025 Q2 Earnings Mixed Performance as Net Income Falls 8.2% - AInvest
Deutsche Bank Adjusts DaVita Price Target to $137 From $165, Maintains Hold Rating - MarketScreener
DaVita Inc. Exceeds Expectations with Strong Q2 2025 Revenue GrowthNews and Statistics - IndexBox
DaVita reiterates $2.01B–$2.16B adjusted operating income guidance for 2025 as cost controls offset volume headwinds - MSN
DaVita HealthCare: Q2 Earnings Snapshot - Greenwich Time
DaVita Inc (DVA) Q2 2025 Earnings Call Highlights: Navigating Challenges with Resilience and ... - uk.finance.yahoo.com
DaVita Inc (DVA) Q2 2025 Earnings Call Highlights: Navigating Ch - GuruFocus
DaVita Inc (DVA) Q2 2025 Earnings Call Highlights: Navigating Challenges with Resilience and ... By GuruFocus - Investing.com Canada
DaVita Inc. (DVA) Stock Forecasts - Yahoo Finance
DaVita Inc. (DVA): Mastering Capital Allocation in a High-Margin Dialysis Industry - AInvest
Strategic Cost Management as the Cornerstone of DaVita's Resilient Operational Performance in 2025 - AInvest
Can DaVita's Pattern of Revenue Outperformance Shape Its Broader Growth Narrative? (DVA) - simplywall.st
DaVita Outpaces Expectations Despite Cyberattack And Hurricane Setbacks - Finimize
Earnings call transcript: DaVita Q2 2025 beats estimates, stock dips - Investing.com
DaVita Inc reports results for the quarter ended June 30Earnings Summary - TradingView
DaVita’s (NYSE:DVA) Q2 Sales Beat Estimates - TradingView
DaVita HealthCare (DVA) Q2 Earnings and Revenues Top Estimates - Yahoo Finance
DAVITA INC. SEC 10-Q Report - TradingView
DaVita beats quarterly profit on steady demand for dialysis services - TradingView
DaVita HealthCare Reports Strong Q2 Earnings, Surpassing ExpectationsNews and Statistics - IndexBox
DaVita Inc Q2 2025 Earnings: Revenue Surpasses Estimates at $3.3 - GuruFocus
DaVita Inc. Q2 Sales Increase - Nasdaq
DaVita earnings beat by $0.17, revenue topped estimates By Investing.com - Investing.com South Africa
DaVita earnings beat by $0.17, revenue topped estimates - Investing.com Australia
DaVita Inc Q2 2025 Earnings: Revenue Surpasses Estimates at $3.38 Billion, Adjusted EPS Beats at $2.95 - GuruFocus
DaVita Inc. 2nd Quarter 2025 Results - PR Newswire
Berkshire Hathaway buys $106.5M in Sirius XM, cuts $230M in DaVita - MSN
Dialysis company DaVita says more than 900,000 people affected by April ransomware attack - The Record from Recorded Future News
Investors Aren't Entirely Convinced By DaVita Inc.'s (NYSE:DVA) Earnings - simplywall.st
Berkshire Hathaway Boosts Sirius XM Stake to 37%, Sells DaVita Shares - WebProNews
Warren Buffett's Berkshire Hathaway Offloads $230 Million In DaVita Stock Ahead Of Q2 Earnings - inkl
Berkshire Hathaway Buys More Sirius XM Stock, Sells DaVita Shares in Recent Days - Barron's
Berkshire Hathaway buys $106.5M in Sirius XM, cuts $230M in DaVita (SIRI:NASDAQ) - Seeking Alpha
Insider Transactions Reported | DaVita(DVA)saw insider trading activity on 8/4/2025 - AInvest
Akebia Initiates Vafseo® (vadadustat) Post-Marketing Study in Conjunction with Large Dialysis Organization - Stock Titan
DaVita (DVA) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Is DaVita Inc. stock overvalued or undervaluedMaximize returns with strategic trading plans - Jammu Links News
Is DaVita Inc. a good long term investmentBreakout portfolio performance - Jammu Links News
Davita Inc Stock (DVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):